Cairo – Mubasher: The ordinary general meeting (OGM) of The Arab Drug Company approved a cash dividend distribution of EGP 4.80 per share to its shareholders for fiscal year (FY) 2021/2022.
Moreover, the EGX-listed company will pay a total of EGP 7.19 million in cash dividends to its employees for FY21/22, according to a stock exchange filing on Tuesday.
It is worth noting that during the period from July 2021 to June 2022, the company logged EGP 76.60 million in net profits after tax, compared with EGP 102 million a year earlier.
In the meantime, the company’s revenues retreated to EGP 512.41 million during FY21/22, compared to EGP 537.04 million in FY20/21.
